| Urinary biomarkers in bladder cancer: A review of the current landscape and future directions K Ng, A Stenzl, A Sharma, N Vasdev Urologic Oncology: Seminars and Original Investigations 39 (1), 41-51, 2021 | 140 | 2021 |
| Metastatic hormone-sensitive prostate cancer (mHSPC): advances and treatment strategies in the first-line setting K Ng, S Smith, J Shamash Oncology and therapy 8 (2), 209-230, 2020 | 85 | 2020 |
| The global economic crisis: effects on mental health and what can be done KH Ng, M Agius, R Zaman Journal of the Royal Society of Medicine 106 (6), 211-214, 2013 | 63 | 2013 |
| Rituximab-induced Takotsubo syndrome: more cardiotoxic than it appears? KH Ng, C Dearden, P Gruber Case Reports 2015, bcr2014208203, 2015 | 50 | 2015 |
| Cardiovascular outcomes and hospitalizations in Asian patients receiving immune checkpoint inhibitors: a population-based study JSK Chan, I Lakhani, TTL Lee, OHI Chou, YHA Lee, YM Cheung, ... Current Problems in Cardiology 48 (1), 101380, 2023 | 34 | 2023 |
| Biomarkers in bladder cancer surveillance SS Sugeeta, A Sharma, K Ng, A Nayak, N Vasdev Frontiers in Surgery 8, 735868, 2021 | 33 | 2021 |
| JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications MD Russell, C Stovin, E Alveyn, O Adeyemi, CKD Chan, V Patel, MA Adas, ... Annals of the rheumatic diseases 82 (8), 1059-1067, 2023 | 27 | 2023 |
| Prostate cancer disparities in risk group at presentation and access to treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: a study with disaggregated … B Jain, K Ng, PMG Santos, K Taparra, V Muralidhar, BA Mahal, ... JCO oncology practice 18 (1), e204-e218, 2022 | 26 | 2022 |
| Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches V Gómez, R Mustapha, K Ng, T Ng British journal of clinical pharmacology 86 (9), 1726-1735, 2020 | 22 | 2020 |
| Annual review of children with tuberous sclerosis KH Ng, SM Ng, A Parker Archives of Disease in Childhood-Education and Practice 100 (3), 114-121, 2015 | 21 | 2015 |
| Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England K Ng, P Wilson, K Mutsvangwa, L Hounsome, J Shamash Prostate Cancer and Prostatic Diseases 24 (3), 718-724, 2021 | 19 | 2021 |
| Risk of new-onset prostate cancer for metformin versus sulfonylurea use in type 2 diabetes mellitus: a propensity score–matched study YHA Lee, J Zhou, JMH Hui, X Liu, TTL Lee, K Hui, JSK Chan, AKC Wai, ... Journal of the National Comprehensive Cancer Network 20 (6), 674-682. e15, 2022 | 17 | 2022 |
| Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based study YHA Lee, JMH Hui, JSK Chan, K Liu, EC Dee, K Ng, P Tang, G Tse, ... The Prostate 83 (1), 119-127, 2023 | 15 | 2023 |
| Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis JSK Chan, P Tang, JMH Hui, YHA Lee, EC Dee, K Ng, K Liu, G Tse, ... The Prostate 82 (15), 1477-1480, 2022 | 15 | 2022 |
| Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans JM Vicencio, R Evans, R Green, Z An, J Deng, C Treacy, R Mustapha, ... Cell Death & Disease 13 (3), 274, 2022 | 14 | 2022 |
| Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era K Ng, K Vinnakota, A Sharma, J Kelly, P Dasgupta, N Vasdev Nature Reviews Urology 18 (4), 185-187, 2021 | 13 | 2021 |
| Insights into unveiling a potential role of tertiary lymphoid structures in metastasis R Mustapha, K Ng, J Monypenny, T Ng Frontiers in Molecular Biosciences 8, 661516, 2021 | 12 | 2021 |
| Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men N Swami, YA Baez, I Franco, T Nguyen, K Meiyappan, M Ton, B Jain, ... Prostate cancer and prostatic diseases 26 (2), 309-316, 2023 | 11 | 2023 |
| An in-depth review of niraparib in ovarian cancer: mechanism of action, clinical efficacy and future directions M Akay, IG Funingana, G Patel, R Mustapha, E Gjafa, T Ng, K Ng, ... Oncology and Therapy 9, 347-364, 2021 | 11 | 2021 |
| Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study JSK Chan, DI Satti, YHA Lee, JMH Hui, EC Dee, K Ng, K Liu, G Tse, ... British Journal of Cancer 128 (12), 2253-2260, 2023 | 9 | 2023 |
Paul Richard BarberGSKVerified email at gsk.com
